ERCC1 expression and RAD51B activity correlate with cell cycle response to platinum drug treatment not DNA repair

Cancer Chemotherapy and Pharmacology

Volumn 63, Issue 4, 2009, Pages 661-672

  Stordal, Britta ^a   Davey, Ross ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cell cycle; Cisplatin; DNA repair; ERCC1; Oxaliplatin; p21; RAD51B; Resistance; Small cell lung cancer

Indexed keywords

CISPLATIN; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; MUTANT PROTEIN; OXALIPLATIN; PROTEIN P21; PROTEIN P53; RAD51 PROTEIN; RAD51B PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER RESISTANCE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CONTROLLED STUDY; DNA REPAIR; DRUG MECHANISM; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CISPLATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA REPAIR; DNA, NEOPLASM; DNA-BINDING PROTEINS; ENDONUCLEASES; GLUTATHIONE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; ORGANOPLATINUM COMPOUNDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMALL CELL LUNG CARCINOMA; TUMOR CELLS, CULTURED;

EID: 58849097981     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0783-x     Document Type: Article

References (44)

1. BK Stordal MW Davey RA Davey 2006 Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells Cancer Chemother Pharmacol 58 256 265
2. B Stordal G Peters R Davey 2006 Similar chromosomal changes in cisplatin and oxaliplatin-resistant sublines of the H69 SCLC cell line are not associated with platinum resistance Genes Chromosomes Cancer 45 1094 1105
3. S Rozen H Skaletsky 2000 Primer3 on the WWW for general users and for biologist programmers Methods Mol Biol 132 365 386
4. S Henness MW Davey RM Harvie RA Davey 2002 Fractionated irradiation of H69 small-cell lung cancer cells causes stable radiation and drug resistance with increased MRP1, MRP2, and topoisomerase IIalpha expression Int J Radiat Oncol Biol Phys 54 895 902
5. A Husain G He ES Venkatraman DR Spriggs 1998 BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II) Cancer Res 58 1120 1123
6. ER McDonald III GS Wu T Waldman WS el Deiry 1996 Repair Defect in p21 WAF1/CIP1 -/- human cancer cells Cancer Res 56 2250 2255
7. HD Preisler V Gopal 1994 Regrowth resistance in leukemia and lymphoma: the need for a new system to classify treatment failure and for new approaches to treatment Leuk Res 18 149 160
8. A Sancar LA Lindsey-Boltz K Unsal-Kacmaz S Linn 2004 Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints Annu Rev Biochem 73 39 85
9. ES Child DJ Mann 2006 The intricacies of p21 phosphorylation: protein/protein interactions, subcellular localization and stability Cell Cycle 5 1313 1319
10. R Altaha X Liang JJ Yu E Reed 2004 Excision repair cross complementing-group 1: gene expression and platinum resistance Int J Mol Med 14 959 970
11. JJ Yu C Mu M Dabholkar Y Guo F Bostick-Bruton E Reed 1998 Alternative splicing of ERCC1 and cisplatin-DNA adduct repair in human tumor cell lines Int J Mol Med 1 617 620
12. M Takata MS Sasaki E Sonoda T Fukushima C Morrison JS Albala SM Swagemakers R Kanaar LH Thompson S Takeda 2000 The Rad51 paralog Rad51B promotes homologous recombinational repair Mol Cell Biol 20 6476 6482
13. M Takata MS Sasaki S Tachiiri T Fukushima E Sonoda D Schild LH Thompson S Takeda 2001 Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs Mol Cell Biol 21 2858 2866
14. Y Yonetani H Hochegger E Sonoda S Shinya H Yoshikawa S Takeda M Yamazoe 2005 Differential and collaborative actions of Rad51 paralog proteins in cellular response to DNA damage Nucleic Acids Res 33 4544 4552
15. PA Havre M Rice R Ramos EB Kmiec 2000 HsRec2/Rad51L1, a protein influencing cell cycle progression, has protein kinase activity Exp Cell Res 254 33 44
16. E Raderschall A Bazarov J Cao R Lurz A Smith W Mann HH Ropers JM Sedivy EI Golub E Fritz T Haaf 2002 Formation of higher-order nuclear Rad51 structures is functionally linked to p21 expression and protection from DNA damage-induced apoptosis J Cell Sci 115 153 164
17. JS Russell K Brady WE Burgan MA Cerra KA Oswald K Camphausen PJ Tofilon 2003 Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity Cancer Res 63 7377 7383
18. TT Paull EP Rogakou V Yamazaki CU Kirchgessner M Gellert WM Bonner 2000 A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage Curr Biol 10 886 895
19. K Rothkamm I Kruger LH Thompson M Lobrich 2003 Pathways of DNA double-strand break repair during the mammalian cell cycle Mol Cell Biol 23 5706 5715
20. LF Qin IO Ng 2001 Exogenous expression of p21(WAF1/CIP1) exerts cell growth inhibition and enhances sensitivity to cisplatin in hepatoma cells Cancer Lett 172 7 15
21. H Lincet L Poulain JS Remy E Deslandes F Duigou P Gauduchon C Staedel 2000 The p21(cip1/waf1) cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells Cancer Lett 161 17 26
22. CH Hensel RH Xiang AY Sakaguchi SL Naylor 1991 Use of the single strand conformation polymorphism technique and PCR to detect p53 gene mutations in small cell lung cancer Oncogene 6 1067 1071
23. LF Qin IO Ng 2002 Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells Cancer Lett 175 27 38
24. T Hata H Yamamoto CY Ngan M Koi A Takagi B Damdinsuren M Yasui Y Fujie T Matsuzaki H Hemmi X Xu K Kitani Y Seki I Takemasa M Ikeda M Sekimoto N Matsuura M Monden 2005 Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells Mol Cancer Ther 4 1585 1594
25. Amati B, Alevizopoulos K, Vlach J (1998) Myc and the cell cycle. Front Biosci d250-d268
26. L Poulain H Lincet F Duigou E Deslandes F Sichel P Gauduchon C Staedel 1998 Acquisition of chemoresistance in a human ovarian carcinoma cell is linked to a defect in cell cycle control Int J Cancer 78 454 463
27. SG Chaney SL Campbell E Bassett Y Wu 2005 Recognition and processing of cisplatin- and oxaliplatin-DNA adducts Crit Rev Oncol Hematol 53 3 11
28. RVN Lord J Brabender D Gandara V Alberola C Camps M Domine F Cardenal JM Sanchez PH Gumerlock M Taron JJ Sanchez KD Danenberg PV Danenberg R Rosell 2002 Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer Clin Cancer Res 8 2286 2291
29. KA Olaussen A Dunant P Fouret E Brambilla F Andre V Haddad E Taranchon M Filipits R Pirker HH Popper R Stahel L Sabatier JP Pignon T Tursz T Le Chevalier JC Soria BIA LT 2006 I, DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy N Engl J Med 355 983 991
30. M Dabholkar J Vionnet F Bostick-Bruton JJ Yu E Reed 1994 Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy J Clin Invest 94 703 708
31. R Napieralski K Ott M Kremer K Specht H Vogelsang K Becker M Muller F Lordick U Fink SJ Rudiger H Hofler G Keller 2005 Combined GADD45A and thymidine phosphorylase expression levels predict response and survival of neoadjuvant-treated gastric cancer patients Clin Cancer Res 11 3025 3031
32. FM Wachters LS Wong W Timens HH Kampinga HJ Groen 2005 ERCC1, hRad51, and BRCA1 protein expression in relation to tumour response and survival of stage III/IV NSCLC patients treated with chemotherapy Lung Cancer 50 211 219
33. R Rosell E Felip M Taron J Majo P Mendez M Sanchez-Ronco C Queralt JJ Sanchez J Maestre 2004 Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery Clin Cancer Res 10 4215s 4219s
34. G Bepler I Kusmartseva S Sharma A Gautam A Cantor A Sharma G Simon 2006 RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer J Clin Oncol 24 4731 4737
35. KM Darcy C Tian E Reed 2007 A Gynecologic Oncology Group study of platinum-DNA adducts and excision repair cross-complementation group 1 expression in optimal, stage III epithelial ovarian cancer treated with platinum-taxane chemotherapy Cancer Res 67 4474 4481
36. F Nunez MD Chipchase AR Clarke DW Melton 2000 Nucleotide excision repair gene (ERCC1) deficiency causes G2 arrest in hepatocytes and a reduction in liver binucleation: the role of p53 and p21 FASEB J 14 1073 1082
37. Weeda G, Donker I, de Wit J, Morreau H, Janssens R, Vissers CJ, Nigg A, van Steeg H, Bootsma D, Hoeijmakers JH (1997) Disruption of mouse ERCC1 results in a novel repair syndrome with growth failure, nuclear abnormalities and senescence. Curr Biol 7:427-439
38. PA Havre MC Rice M Noe EB Kmiec 1998 The human REC2/RAD51B gene acts as a DNA damage sensor by inducing G1 delay and hypersensitivity to ultraviolet irradiation Cancer Res 58 4733 4739
39. IY Chang MH Kim BH Kim DY Lee SH Kim HY Kim HJ You 2005 Small interfering RNA-induced suppression of ERCC1 enhances sensitivity of human cancer cells to cisplatin Biochem Biophys Res Commun 327 225 233
40. DW Melton AM Ketchen F Nunez S Bonatti-Abbondandolo A Abbondandolo S Squires RT Johnson 1998 Cells from ERCC1-deficient mice show increased genome instability and a reduced frequency of S-phase-dependent illegitimate chromosome exchange but a normal frequency of homologous recombination J Cell Sci 111 395 404
41. RG Sargent JL Meservy BD Perkins AE Kilburn Z Intody GM Adair RS Nairn JH Wilson 2000 Role of the nucleotide excision repair gene ERCC1 in formation of recombination-dependent rearrangements in mammalian cells Nucleic Acids Res 28 3771 3778
42. C Richardson JM Stark M Ommundsen M Jasin 2004 Rad51 overexpression promotes alternative double-strand break repair pathways and genome instability Oncogene 23 546 553
43. JC Harrison JE Haber 2006 Surviving the breakup: the DNA damage checkpoint Annu Rev Genet 40 209 235
44. RG Syljuasen S Jensen J Bartek J Lukas 2006 Adaptation to the ionizing radiation-induced G2 checkpoint occurs in human cells and depends on checkpoint kinase 1 and Polo-like kinase 1 kinases Cancer Res 66 10253 10257